Anika Therapeutics Q3: Net Loss, Adjusted Gains, & Stock Decline
Update: 2025-11-05
Description
Anika Therapeutics, a medical technology company, reported a net loss of $2.3 million for Q3, translating to a loss of $0.16 per share. However, after adjusting for one-time gains and costs, the company saw a positive adjusted earnings of $0.04 per share. The company generated $27.8 million in revenue during the quarter. Despite these figures, Anika's stock has faced challenges, with a 41% decrease since the beginning of the year and a 44% drop over the past twelve months. Investors and industry watchers will closely monitor the company's performance in the coming quarters.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
